Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
Affymetrix Commercializes Next-Generation Transcriptome Array For Large-Scale Clinical Studies

Affymetrix Commercializes Next-Generation Transcriptome Array For Large-Scale Clinical Studies

Affymetrix, Inc. (NASDAQ:AFFX) today announced commercialization of the next-generation human transcriptome array demonstrated by Stanford University researchers to be superior to mRNA sequencing (RNA-Seq) in gene...

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix Inc. Stock Downgraded (AFFX)

Affymetrix (Nasdaq:AFFX) has been downgraded by TheStreet Ratings from from a hold to sell.

Affymetrix To Release Axiom Array Plates Optimized For NIH-funded Genotyping Study Of 100,000 People

Affymetrix To Release Axiom Array Plates Optimized For NIH-funded Genotyping Study Of 100,000 People

Affymetrix, Inc. (NASDAQ: AFFX) today announced plans to commercialize four Axiom ® population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation’s largest and...

Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Affymetrix Reports Second Quarter Results

Affymetrix Reports Second Quarter Results

Affymetrix, Inc. (NASDAQ: AFFX) today reported its operating results for the second quarter of 2011.

5 More Earnings Stocks Set to Soar

5 More Earnings Stocks Set to Soar

These heavily shorted stocks could get squeezed higher if they report positive earnings.

Affymetrix Begins Shipment Of Industry’s First FDA-cleared Gene Profiling Reagents

Affymetrix Begins Shipment Of Industry’s First FDA-cleared Gene Profiling Reagents

Affymetrix, Inc. (NASDAQ:AFFX) today began shipping its FDA-cleared Gene Profiling Reagents.

Affymetrix Stock Gaps Down On Today's Open (AFFX)

Affymetrix Stock Gaps Down On Today's Open (AFFX)

Shares of Affymetrix (Nasdaq:AFFX) were gapping down Thursday morning with an open price 17.5% lower than Wednesday's closing price. The stock closed at $8 yesterday and opened today's trading at $6.60.

Affymetrix, Tessera: After-Hours Trading

Affymetrix, Tessera: After-Hours Trading

Shares of Affymetrix fall in Wednesday's extended session after the company give a disappointing revenue outlook.

Affymetrix Announces Preliminary Revenue For Second Quarter 2011

Affymetrix Announces Preliminary Revenue For Second Quarter 2011

Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue for the second quarter of 2011 to be in the range of $64-65 million.

Affymetrix Reaches New 52-Week High (AFFX)

Affymetrix Reaches New 52-Week High (AFFX)

Affymetrix (Nasdaq:AFFX) hit a new 52-week high Wednesday as it is currently trading at $7.89, above its previous 52-week high of $7.88 with 431,587 shares traded as of 11:26 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Study Shows Strong Future Demand For Affymetrix Microarrays

Study Shows Strong Future Demand For Affymetrix Microarrays

A recent study conducted by global industry analysts Frost & Sullivan clarifying the state and dynamics of genomic technology adoption and utilization in the U.

Affymetrix Debuts Social Media Presence, Ranked 5th Among All Life Science Companies On Twitter

Affymetrix Debuts Social Media Presence, Ranked 5th Among All Life Science Companies On Twitter

In third graph, first sentence, Twitter username should read @genomicapps (sted @gemomicapps).

Affymetrix Stock Hits New 52-Week High (AFFX)

Affymetrix Stock Hits New 52-Week High (AFFX)

Affymetrix (Nasdaq:AFFX) hit a new 52-week high Wednesday as it is currently trading at $7.54, above its previous 52-week high of $7.44 with 520,863 shares traded as of 10:06 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.

Proven Performance From The Industry Standard The Affymetrix(R) Human Genome U133+ PM Array Strip Enables Expression Profiling Of Four Samples At A Time Using The Same Content As The GeneChip(R) HT HG-U133+ PM Array Plate, Which Is Based On The Industry-standard GeneChip(R) Human Genome U133 Plus 2.0 Array.* (Photo: Business Wire)

Proven Performance From The Industry Standard The Affymetrix(R) Human Genome U133+ PM Array Strip Enables Expression Profiling Of Four Samples At A Time Using The Same Content As The GeneChip(R) HT HG-U133+ PM Array Plate, Which Is Based On The Industry-standard GeneChip(R) Human Genome U133 Plus 2.0 Array.* (Photo: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) today announced the availability of the most widely cited gene expression microarray for use on the GeneAtlas ® Personal Microarray System, bringing the power of the world’s largest ...

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look poised to break out and trade higher from current levels

Affymetrix Stock Hits New 52-Week High (AFFX)

Affymetrix Stock Hits New 52-Week High (AFFX)

Affymetrix (Nasdaq:AFFX) hit a new 52-week high Friday as it is currently trading at $7.09, above its previous 52-week high of $7.08 with 1.3 million shares traded as of 11:06 a.m. ET. Average volume has been 962,300 shares over the past 30 days.

Affymetrix Rises On Unusually High Volume (AFFX)

Affymetrix Rises On Unusually High Volume (AFFX)

Affymetrix (Nasdaq:AFFX) is trading at unusually high volume Wednesday with 3.9 million shares changing hands. It is currently at 4.3 times its average daily volume and trading up 19 cents (+3.1%).

Affymetrix Appoints Frank Witney, Ph.D., As President And Chief Executive Officer

Affymetrix Appoints Frank Witney, Ph.D., As President And Chief Executive Officer

Affymetrix, Inc. (Nasdaq: AFFX) today announced that Dr.

Affymetrix Selects BioDiscovery As OncoScan™ FFPE Express Preferred Software Provider

Affymetrix Selects BioDiscovery As OncoScan™ FFPE Express Preferred Software Provider

Affymetrix, Inc. (NASDAQ:AFFX) today announced a co-marketing agreement naming BioDiscovery, Inc.

Affymetrix Adds New Tools For Targeted Genotyping Market To Accelerate Disease Studies

Affymetrix Adds New Tools For Targeted Genotyping Market To Accelerate Disease Studies

Affymetrix, Inc. (NASDAQ:AFFX) today launched new Axiom™ myDesign™ Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and...

Affymetrix Releases New Applied Research Arrays Designed With Scientific Leaders

Affymetrix Releases New Applied Research Arrays Designed With Scientific Leaders

Affymetrix, Inc. (NASDAQ:AFFX) today announced the availability of multiple genomic microarray tools that will further enable scientists in the applied research field.

Affymetrix Achieves First FDA Clearance Of Microarray-Based Gene Profiling Reagents

Affymetrix Achieves First FDA Clearance Of Microarray-Based Gene Profiling Reagents

Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.

Affymetrix To Webcast Annual Meeting Of Shareholders

Affymetrix To Webcast Annual Meeting Of Shareholders

Affymetrix, Inc. (Nasdaq:AFFX) today invited investors and interested parties to hear a live webcast of its Annual Shareholder Meeting at 9:00am PT on Thursday May 5 th, 2011.

Affymetrix To Webcast Presentations From May Financial Conferences

Affymetrix To Webcast Presentations From May Financial Conferences

Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide a corporate overview at the following financial conferences in May.

Affymetrix Stock Gaps Down On Today's Open (AFFX)

Affymetrix Stock Gaps Down On Today's Open (AFFX)

Shares of Affymetrix (Nasdaq:AFFX) were gapping down Thursday morning with an open price 10.1% lower than Wednesday's closing price. The stock closed at $5.83 yesterday and opened today's trading at $5.24.

Affymetrix's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Affymetrix Reports First Quarter Results

Affymetrix Reports First Quarter Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2011.

Affymetrix To Host Conference Call On April 27, 2011 To Announce First Quarter Results

Affymetrix To Host Conference Call On April 27, 2011 To Announce First Quarter Results

Affymetrix, Inc. (NASDAQ:AFFX) today announced its first quarter 2011 financial results will be reported on Wednesday, April 27, 2011, after market close.

Affymetrix Releases Axiom™ Genome-Wide CHB 1 Array

Affymetrix Releases Axiom™ Genome-Wide CHB 1 Array

Affymetrix, Inc. (NASDAQ:AFFX) today announced the expansion of its Axiom product line with the launch of the Axiom™ Genome-Wide CHB 1 Array, the first commercial product to maximize genetic coverage of common...